后节葡萄膜炎患者全外显子组测序研究
本研究对164例临床诊断的后节葡萄膜炎患者行全外显子组测序,在23个基因中检出203个单核苷酸变异,包括NOD2、CAPN5等已知基因及既往未与后节葡萄膜炎关联的基因变异;蛋白结构建模与计算分析提示多数变异与野生型明显不同,涉及新的免疫信号通路。
要点
- 在164例后节葡萄膜炎患者23个基因中检出203个单核苷酸变异,含已知与新型变异。
- NOD样受体家族基因、CAPN5与TYK2的错义变异经结构建模预测可改变蛋白结构与功能。
- 全外显子组测序在特定病例中有助诊断携带已知综合征性炎症疾病变异的非综合征性葡萄膜炎。
核心结论
- 后节葡萄膜炎易感性可能涉及新的通路与免疫信号蛋白,所检出变异的致病性尚需更大队列与功能研究验证。
研究设计与样本
- 遗传关联队列研究,单中心学术转诊中心开展,研究人群为164例临床诊断的后节葡萄膜炎患者,采用外显子测序检测变异。
主要发现
- 164例患者在23个基因中共纳入203个单核苷酸变异,包括已知与新型变异。
- 在NOD2(Blau综合征)与CAPN5(新生血管性炎症性玻璃体视网膜病变)等既往与特定综合征性葡萄膜炎相关基因中检出已知及新型变异。
- 还检出既往未与后节葡萄膜炎关联的基因变异。
- 基于排序列表与蛋白-蛋白相互作用网络,对NOD样受体家族基因(NOD2、NLRC4、NLRP3、NLRP1)、CAPN5与TYK2的错义变异行结构建模与计算预测。
- 所分析的大多数变异与野生型明显不同。
关键数值与推荐
- 共203个单核苷酸变异,分布于23个基因、164例患者。
临床怎么用
- 在特定病例中,全外显子组测序可帮助诊断携带已知综合征性炎症疾病变异的非综合征性葡萄膜炎患者。
局限性
- 作者指出需更大队列与功能研究以验证所检出突变的致病性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To elucidate molecular risk factors for posterior segment uveitis using a functional genomics approach. DESIGN: Genetic association cohort study. METHODS: Setting: Single-center study at an academic referral center. STUDY POPULATION: 164 patients with clinically diagnosed uveitis of the posterior segment. MAIN OUTCOME MEASURES: Exome sequencing was used to detect variants identified in 164 patients with posterior segment uveitis. A phenotype-driven analysis, protein structural modeling, and in silico calculations were then used to rank and predict the functional consequences of key variants. RESULTS: A total of 203 single nucleotide variants, in 23 genes across 164 patients, were included in this study. Both known and novel variants were identified in genes previously implicated in specific types of syndromic uveitis-such as NOD2 (Blau syndrome) and CAPN5 NIV (neovascular inflammatory vitreoretinopathy)-as well as variants in genes not previously linked to posterior segment uveitis. Based on a ranked list and protein-protein-interaction network, missense variants in NOD-like receptor family genes (NOD2, NLRC4, NLRP3, and NLRP1), CAPN5, and TYK2 were characterized via structural modeling and in silico calculations to predict how specific variants might alter protein structure and function. The majority of analyzed variants were notably different from wild type. CONCLUSIONS: This study implicates new pathways and immune signaling proteins that may be associated with posterior segment uveitis susceptibility. A larger cohort and functional studies will help validate the pathogenicity of the mutations identified. In specific cases, whole-exome sequencing can help diagnose nonsyndromic uveitis in patients harboring known variants for syndromic inflammatory diseases.
引用
- Li AS, Velez G, Darbro B, et al. Whole-Exome Sequencing of Patients With Posterior Segment Uveitis. Am J Ophthalmol. 2020. PMID: 32707200. doi:10.1016/j.ajo.2020.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。